+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06289699

Study of Alert Frequency and Satisfaction With Wireless Continuous Vital Sign Monitoring in Hospital Patients and Nurses

Led by Christian S. Meyhoff · Updated on 2025-08-12

100

Participants Needed

5

Research Sites

21 weeks

Total Duration

AI-Summary

What this Trial Is About

This research aims to evaluate the functionality and user experience of a new wireless, continuous vital sign monitoring system across multiple international hospital centers. It includes patients admitted for surgery lasting more than two hours or acute medical conditions with specific vital sign deviations. The study also explores current hospital monitoring practices and assesses nurse and patient satisfaction with the monitoring system. Patients will be monitored using validated FDA or CE approved wireless devices such as Sotera Visimobile or Isansys Lifeguard, paired with the CE approved WARD web and mobile application. Monitoring will occur for 4 days after surgery or acute admission and continue until discharge. Nurses responsible for patients during full shifts will provide feedback through questionnaires. Participants will undergo standard vital sign monitoring alongside the new system. Researchers will collect data on alert frequencies, technical feasibility, alert responses, and patient experiences using questionnaires and semi-structured interviews. Monitoring practices before system use will also be reviewed. The main outcome is the frequency of alerts activated versus expected alerts during about three months of monitoring.

CONDITIONS

Brief Title

Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures

Research Team

K

Katja K Head of Clinical, MD

E

Eske Kvanner Aasvang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here